Status:

NOT_YET_RECRUITING

AI-Assisted Comprehensive Management for Cancer Patients With Comorbidities (GCOG-CG001)

Lead Sponsor:

The First Affiliated Hospital of Xinxiang Medical College

Conditions:

Oncological Comorbidities (e. g. Hypertension, Diabetes, Malnutrition)

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Combined with the digital whole process management data pool, a multi-modal data fusion framework is developed, and an AI model is established to realize risk stratification and personalized treatment...

Detailed Description

The title of this study is"The Impact of Multimodal Digital Fusion AI-Assisted Decision Support System-Based Comprehensive Management on Clinical Outcomes in County-Level Patients with Comorbid Cancer...

Eligibility Criteria

Inclusion

  • Patients with a definite diagnosis of malignancy by histopathology and/or cytology;
  • Age ≥18 years;
  • There is no gender limit
  • Plan to receive antineoplastic therapy within 2 weeks or are receiving standard antineoplastic care (surgery, radiation, chemotherapy, or targeted therapy) ;
  • Conscious and able to answer questions and use electronic devices autonomously;
  • Patients were able to understand the study and voluntarily sign an informed consent form;

Exclusion

  • Having severe mental or cognitive impairments that prevent them from understanding the content of the study or implementing the programme;
  • With severe heart disease, acute respiratory failure, liver kidney failure and other critical illness;
  • Women during pregnancy or lactation;
  • Have participated in other interventional studies in the past 1 month or are currently participating;
  • Patients with ECOG ≥ 3 that do not respond to treatment;
  • Patients with an expected survival of \< 3 months that do not respond to treatment;
  • Cases deemed unsuitable for enrollment by the investigator.

Key Trial Info

Start Date :

August 15 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2031

Estimated Enrollment :

5000 Patients enrolled

Trial Details

Trial ID

NCT07136727

Start Date

August 15 2025

End Date

May 1 2031

Last Update

August 22 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The First Affiliated Hospital of Xinxiang Medical University

Xinxiang, Henan, China, 453000

AI-Assisted Comprehensive Management for Cancer Patients With Comorbidities (GCOG-CG001) | DecenTrialz